Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Prevacent PRRS
- Development stage
- Unknown
- Lead developer
- Elanco
- Modality
- Live Attenuated Vaccines → Live Vaccines → Prophylactic Vaccines → Vaccines & Immunotherapeutics
- Administration
- Intramuscular
01
Overview
Prevacent PRRS is a modified-live virus (MLV) vaccine developed by Elanco for the immunization of healthy swine against porcine reproductive and respiratory syndrome virus (PRRSV). It specifically contains a live attenuated Lineage 1, Type 2 PRRSV strain (GenBank accession KU131568). The vaccine is indicated for pigs 2 weeks of age or older to prevent the respiratory form of the disease and for sows/gilts 6 weeks prior to breeding to prevent reproductive failure. It is the first Lineage 1 PRRS vaccine on the market, offering protection against contemporary field strains like NADC20 and NC174. The product is administered as a 1 mL intramuscular injection and provides a duration of immunity of up to 26 weeks.
- Brand names
- Prevacent PRRS
Beyond the preview
Go deeper on Prevacent PRRS.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Prevacent PRRS.